eu – pharma.markets

EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

20/02/2021 MaP 0

The European Union has announced today an additional €500 million for the COVAX Facility, doubling its contribution to date for the global initiative that is […]

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

17/02/2021 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses […]

EU boosts humanitarian aid budget for 2021 as needs rise

26/01/2021 MaP 0

As global humanitarian needs worsen further due to the consequences of the coronavirus pandemic and the effects of climate change, the European Commission has adopted […]

EIB provides €20 million to support RDI activities and growth at Galenicum

26/01/2021 MaP 0

The European Investment Bank (EIB) will provide €20 million to finance the research, development and innovation (RDI) programme of Galenicum, a pharmaceutical company founded in […]

Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine

08/01/2021 MaP 0

We are in talks with the European Commission (EC) about an amendment to our existing supply agreement for COMIRNATY®, the Pfizer-BioNTech COVID-19 Vaccine. The amendment […]

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

29/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, […]

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine COMIRNATY

21/12/2020 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer […]

State aid: EU Commission gives green light to the Pan-European Guarantee Fund to enable up to €200 billion …

14/12/2020 MaP 0

…financing for companies affected by the coronavirus outbreak in 21 Member States The European Commission found the creation of a €25 billion Pan-European Guarantee Fund […]

EU and Member States Vaccine strategies and bestpractices – priority groups

12/12/2020 MaP 0

The Commission has been working closely with Member States to define needs, explore strategies and to exchange information and best practices. In addition, modernising public […]

EU Commission Pharmaceutical Strategy for Europe -Affordable, accessible and safe medicines for all

01/12/2020 MaP 0

The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]

A stronger EU health security framework

01/12/2020 MaP 0

To create a more robust mandate for coordination by the Commission and EU agencies, the Commission is today proposing a new Regulation on serious cross-border […]

Stronger and more operational EU Medicine Agencies

01/12/2020 MaP 0

The European Centre for Disease Control and Prevention and the European Medicines Agency have been at the forefront of the EU’s work to address COVID-19 […]